THIS STORY HAS BEEN FORMATTED FOR EASY PRINTING

Boston Scientific gets FDA OK for 2 heart devices

Email|Print|Single Page| Text size – +
May 13, 2008

NATICK, Mass.—Medical device maker Boston Scientific Co. said Tuesday the Food and Drug Administration approved two of its new heart devices.

The FDA approved the Cognis defibrillator and the Teligen implantable defibrillator, both of which are used to treat heart failure.

Shares of Boston Scientific rose 20 cents to $13.21 in after-hours electronic trading, from their close at $13.01 during the regular trading session.

© Copyright 2008 Associated Press. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

more stories like this

  • Email
  • Email
  • Print
  • Print
  • Single page
  • Single page
  • Reprints
  • Reprints
  • Share
  • Share
  • Comment
  • Comment
 
  • Share on DiggShare on Digg
  • Tag with Del.icio.us Save this article
  • powered by Del.icio.us
Your Name Your e-mail address (for return address purposes) E-mail address of recipients (separate multiple addresses with commas) Name and both e-mail fields are required.
Message (optional)
Disclaimer: Boston.com does not share this information or keep it permanently, as it is for the sole purpose of sending this one time e-mail.